Thematics Asset Management lowered its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 5.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 103,000 shares of the business services provider's stock after selling 6,500 shares during the period. Thematics Asset Management owned about 0.20% of Exponent worth $9,177,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the business. Barclays PLC raised its stake in Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after acquiring an additional 66,263 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Exponent by 223.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after purchasing an additional 4,254 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock valued at $72,701,000 after purchasing an additional 245,086 shares during the last quarter. Argent Capital Management LLC boosted its position in Exponent by 17.3% in the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock valued at $2,524,000 after buying an additional 4,173 shares in the last quarter. Finally, KBC Group NV grew its stake in shares of Exponent by 62.4% during the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock worth $203,000 after buying an additional 874 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.
Insiders Place Their Bets
In other news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.10% of the company's stock.
Exponent Stock Performance
Shares of EXPO traded down $0.99 during trading hours on Thursday, reaching $78.99. The stock had a trading volume of 501,695 shares, compared to its average volume of 245,480. Exponent, Inc. has a 12 month low of $73.83 and a 12 month high of $115.75. The stock has a market capitalization of $4.01 billion, a PE ratio of 37.26 and a beta of 0.84. The company's 50-day moving average is $81.72 and its two-hundred day moving average is $91.49.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period in the prior year, the firm earned $0.41 earnings per share. Equities analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.